~~<i id='1CB606C1B0'><strike id='1CB606C1B0'><tt id='1CB606C1B0'><pre id='1CB606C1B0'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

leisure time

author：Wikipedia 2025-09-27 10:02:13 - browse：2

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

hotspot

leisure time

hotspot

focus

leisure time

hotspot

EssayauthorRichardS.Ostfeldhasdevelopedanimmunitythatkillstickswhentheytrytobitehim.CDCSometimespeop

WSS

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

2 US Navy sailors arrested for allegedly spying for China

Gilgo Beach: Police identify another victim in serial killing investigation

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

Humana, CVS hope to turn members into patients at clinics

Wikipedia

leisure time

hotspot

Medical records are filled with copy

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

Malaria cases in Florida and Texas: Here’s what you need to know

Headspace, Meta partner to launch VR meditation app for Quest

Alkermes shareholders re

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

BioMarin wins approval for gene therapy to treat hemophilia A

With psoriasis trial ahead, Alumis raises $259 million

Anesthesiologist group: stop taking Ozempic before surgery

White House drug shortage group privately met with industry

leisure time

Microsoft strikes partnership with Duke Health to advance health AI

Biden calls for immediate release of Niger's president amid apparent coup

My superpower is killing ticks

NEJM study link tiny plastics in blood vessels to heart problems

OTC birth control: A brief history of over the counter pill design

Influencer to be charged after chaos erupts in New York City's Union Square

hotspot

focus

leisure time

hotspot